Publication | Open Access

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

Bone DiseaseZoledronic AcidBone LossBone HealthBreast OncologyMedicineGynecologyBreast CancerPharmacotherapyOsteoporosisOncologyRadiation OncologyOrthopaedic Surgery